Literature DB >> 1008131

Shock syndrome in primary dengue infections.

R M Scott, S Nimmannitya, W H Bancroft, P Mansuwan.   

Abstract

During 1974, 114 patients with dengue hemorrhagic fever were studied at the Bankok Children's Hospital. Over 40% of the patients had dengue shock syndrome. Five fatal cases were included in the study. Primary dengue infections were identified by absent or low titered antibodies in acute sera and the sequential development of IgM antibodies followed by IgG antibodies during convalescence. Three patients, aged 4,8, and 12 years, had primary dengue infections with shock. Although no convalescent sera could be tested two other patients, aged 7 to 12 years, with fatal disease also appeared to have primary infections. At the time of shock patients with primary infections had subnormal concentrations of complement factor 3. The data show that in older children dengue shock syndrome associated with complement depression can occur during primary as well as secondary infections.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008131     DOI: 10.4269/ajtmh.1976.25.866

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation.

Authors:  M Juffrie; G M van Der Meer; C E Hack; K Haasnoot; A J Veerman; L G Thijs
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Replication of dengue and junin viruses in cultured rabbit and human endothelial cells.

Authors:  B S Andrews; A N Theofilopoulos; C J Peters; D J Loskutoff; W E Brandt; F J Dixon
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections.

Authors:  Sophie Alcon; Antoine Talarmin; Monique Debruyne; Andrew Falconar; Vincent Deubel; Marie Flamand
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Dengue.

Authors: 
Journal:  Br Med J       Date:  1977-11-05

Review 5.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

6.  Kinetics of peripheral blood leukocyte alterations in Thai children with dengue hemorrhagic fever.

Authors:  R A Wells; R M Scott; K Pavanand; V Sathitsathein; U Cheamudon; R P Macdermott
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

7.  A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

Authors:  Kanakatte Raviprakash; Danher Wang; Dan Ewing; David H Holman; Karla Block; Jan Woraratanadharm; Lan Chen; Curtis Hayes; John Y Dong; Kevin Porter
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

Review 8.  Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.

Authors:  Kaitlin Rainwater-Lovett; Isabel Rodriguez-Barraquer; Derek A T Cummings; Justin Lessler
Journal:  BMC Infect Dis       Date:  2012-09-28       Impact factor: 3.090

9.  Participation of the Dengue virus in the fibrinolytic process.

Authors:  V Monroy; B H Ruiz
Journal:  Virus Genes       Date:  2000-10       Impact factor: 2.198

Review 10.  Dengue: an arthropod-borne disease of global importance.

Authors:  A T A Mairuhu; J Wagenaar; D P M Brandjes; E C M van Gorp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.